1
|
Plastin 3 in health and disease: a matter of balance. Cell Mol Life Sci 2021; 78:5275-5301. [PMID: 34023917 PMCID: PMC8257523 DOI: 10.1007/s00018-021-03843-5] [Citation(s) in RCA: 31] [Impact Index Per Article: 10.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2021] [Revised: 04/06/2021] [Accepted: 04/20/2021] [Indexed: 02/06/2023]
Abstract
For a long time, PLS3 (plastin 3, also known as T-plastin or fimbrin) has been considered a rather inconspicuous protein, involved in F-actin-binding and -bundling. However, in recent years, a plethora of discoveries have turned PLS3 into a highly interesting protein involved in many cellular processes, signaling pathways, and diseases. PLS3 is localized on the X-chromosome, but shows sex-specific, inter-individual and tissue-specific expression variability pointing towards skewed X-inactivation. PLS3 is expressed in all solid tissues but usually not in hematopoietic cells. When escaping X-inactivation, PLS3 triggers a plethora of different types of cancers. Elevated PLS3 levels are considered a prognostic biomarker for cancer and refractory response to therapies. When it is knocked out or mutated in humans and mice, it causes osteoporosis with bone fractures; it is the only protein involved in actin dynamics responsible for osteoporosis. Instead, when PLS3 is upregulated, it acts as a highly protective SMN-independent modifier in spinal muscular atrophy (SMA). Here, it seems to counteract reduced F-actin levels by restoring impaired endocytosis and disturbed calcium homeostasis caused by reduced SMN levels. In contrast, an upregulation of PLS3 on wild-type level might cause osteoarthritis. This emphasizes that the amount of PLS3 in our cells must be precisely balanced; both too much and too little can be detrimental. Actin-dynamics, regulated by PLS3 among others, are crucial in a lot of cellular processes including endocytosis, cell migration, axonal growth, neurotransmission, translation, and others. Also, PLS3 levels influence the infection with different bacteria, mycosis, and other pathogens.
Collapse
|
2
|
Le Goff E, Vallentin A, Harmand PO, Aldrian-Herrada G, Rebière B, Roy C, Benyamin Y, Lebart MC. Characterization of L-plastin interaction with beta integrin and its regulation by micro-calpain. Cytoskeleton (Hoboken) 2010; 67:286-96. [PMID: 20183869 DOI: 10.1002/cm.20442] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
Recent evidences suggest that plastin/fimbrin is more than a simple actin cross-linking molecule. In this context and based on the fact that other members of the same family interact with transmembrane proteins, such as integrins, we have investigated a possible interaction between L-plastin and integrins. By combining coimmunoprecipitation of endogenous proteins and in vitro techniques based on solid phase and solution assays, we demonstrate that L-plastin is an additional binding partner for the beta-chain of integrin and confirmed that both proteins display some colocalization. We then show that L-plastin binds to the cytoplasmic domain of beta1 integrin and to beta1 and beta2 peptides. Using recombinant L-plastin domains, we demonstrate that the integrin-binding sites are not located in NH(2) terminal part of L-plastin but rather in the two actin-binding domains. Using pull-down, cross-linking experiments, and enzyme-linked immunosorbent assay, we show that the L-plastin/integrin complex is regulated by mu-calpain cleavage and is not directly dissociated by calcium. Indeed, despite the ability of calpain to cleave both proteins, only the cleavage of beta integrin hindered the formation of the L-plastin/integrin complex. We discuss these results in the light of the three-dimensional structure of the actin-binding domains of L-plastin.
Collapse
Affiliation(s)
- E Le Goff
- UMR CNRS 5554, Institut des Sciences de l'Evolution, Université Montpellier 2, Place Eugène Bataillon, 34095 Montpellier, Cedex 05, France
| | | | | | | | | | | | | | | |
Collapse
|
3
|
The 3D structure of villin as an unusual F-Actin crosslinker. Structure 2009; 16:1882-91. [PMID: 19081064 DOI: 10.1016/j.str.2008.09.015] [Citation(s) in RCA: 34] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2008] [Revised: 09/13/2008] [Accepted: 09/30/2008] [Indexed: 11/23/2022]
Abstract
Villin is an F-actin nucleating, crosslinking, severing, and capping protein within the gelsolin superfamily. We have used electron tomography of 2D arrays of villin-crosslinked F-actin to generate 3D images revealing villin's crosslinking structure. In these polar arrays, neighboring filaments are spaced 125.9 +/- 7.1 A apart, offset axially by 17 A, with one villin crosslink per actin crossover. More than 6500 subvolumes containing a single villin crosslink and the neighboring actin filaments were aligned and classified to produce 3D subvolume averages. Placement of a complete villin homology model into the average density reveals that full-length villin binds to different sites on F-actin from those used by other actin-binding proteins and villin's close homolog gelsolin.
Collapse
|
4
|
Esue O, Tseng Y, Wirtz D. Alpha-actinin and filamin cooperatively enhance the stiffness of actin filament networks. PLoS One 2009; 4:e4411. [PMID: 19198659 PMCID: PMC2635933 DOI: 10.1371/journal.pone.0004411] [Citation(s) in RCA: 49] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/06/2008] [Accepted: 01/09/2009] [Indexed: 11/19/2022] Open
Abstract
BACKGROUND The close subcellular proximity of different actin filament crosslinking proteins suggests that these proteins may cooperate to organize F-actin structures to drive complex cellular functions during cell adhesion, motility and division. Here we hypothesize that alpha-actinin and filamin, two major F-actin crosslinking proteins that are both present in the lamella of adherent cells, display synergistic mechanical functions. METHODOLOGY/PRINCIPAL FINDINGS Using quantitative rheology, we find that combining alpha-actinin and filamin is much more effective at producing elastic, solid-like actin filament networks than alpha-actinin and filamin separately. Moreover, F-actin networks assembled in the presence of alpha-actinin and filamin strain-harden more readily than networks in the presence of either alpha-actinin or filamin. SIGNIFICANCE These results suggest that cells combine auxiliary proteins with similar ability to crosslink filaments to generate stiff cytoskeletal structures, which are required for the production of internal propulsive forces for cell migration, and that these proteins do not have redundant mechanical functions.
Collapse
Affiliation(s)
- Osigwe Esue
- Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, Maryland, United States of America
- Department of Early Stage Pharmaceutical Development, Genentech, Inc., South San Francisco, California, United States of America
| | - Yiider Tseng
- Department of Chemical Engineering, University of Florida, Gainesville, Florida, United States of America
| | - Denis Wirtz
- Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, Maryland, United States of America
- * E-mail:
| |
Collapse
|
5
|
Feng JJ, Marston S. Genotype–phenotype correlations in ACTA1 mutations that cause congenital myopathies. Neuromuscul Disord 2009; 19:6-16. [DOI: 10.1016/j.nmd.2008.09.005] [Citation(s) in RCA: 72] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/23/2008] [Revised: 09/08/2008] [Accepted: 09/09/2008] [Indexed: 12/01/2022]
|
6
|
Popowicz GM, Schleicher M, Noegel AA, Holak TA. Filamins: promiscuous organizers of the cytoskeleton. Trends Biochem Sci 2006; 31:411-9. [PMID: 16781869 DOI: 10.1016/j.tibs.2006.05.006] [Citation(s) in RCA: 226] [Impact Index Per Article: 12.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Revised: 04/28/2006] [Accepted: 05/25/2006] [Indexed: 01/14/2023]
Abstract
Filamins are elongated homodimeric proteins that crosslink F-actin. Each monomer chain of filamin comprises an actin-binding domain, and a rod segment consisting of six (Dictyostelium filamin) up to 24 (human filamin) highly homologous repeats of approximately 96 amino acid residues, which adopt an immunoglobulin-like fold. Two hinges in the rod segment, together with the reversible unfolding of single repeats, might be the structural basis for the intrinsic flexibility of the actin networks generated by filamins. There are numerous filamin-binding proteins that associate, in most cases, along the repeats of the rod repeats. This rather promiscuous behaviour renders filamin a versatile scaffold between the actin network and finely tuned molecular cascades from the membrane to the cytoskeleton.
Collapse
|
7
|
Raynaud F, Fabrice R, Jond-Necand C, Carole JN, Marcilhac A, Anne M, Fürst D, Dieter F, Benyamin Y, Yves B. Calpain 1-gamma filamin interaction in muscle cells: a possible in situ regulation by PKC-alpha. Int J Biochem Cell Biol 2005; 38:404-13. [PMID: 16297652 DOI: 10.1016/j.biocel.2005.09.020] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/26/2005] [Revised: 09/28/2005] [Accepted: 09/30/2005] [Indexed: 10/25/2022]
Abstract
Calpains are a family of calcium-dependent cysteine-proteases involved in cytoskeleton remodelling and muscle differentiation. In a recent study, we observed the presence of calpain 1 in the muscle contractile apparatus and specifically in the N1- and N2-lines. This calpain isoform was found to be involved in the degradation of muscle fibres via proteolysis of key proteins in Z-disk and costameric junctions. The goal of this study was to determine whether gamma-filamin--a specific muscle isoform of the filamin family--is a calpain 1 substrate and to characterise this interaction. Gamma-filamin is a major muscle architectural protein located in the Z-line and under the sarcolemmal membrane. This protein is a component of the chain binding the sarcolemma to the sarcomeric structure. In this study, we found that gamma-filamin formed a stable complex in vitro and in cells with calpain 1 in the absence of calcium stimulation. We also located the binding domains in the C-terminus of gamma-filamin with a cleavage site between serine 2626 and serine 2627 in the hinge 2 region. The catalytic (80 kDa) and regulatory (28 kDa) subunits of calpain 1 are both involved in high affinity binding at gamma-filamin. Moreover, we showed that phosphorylation of the filamin C-terminus domain by PKC alpha protected gamma-filamin against proteolysis by calpain 1 in COS cells. Stimulation of PKC activity in myotubes, prevented gamma-filamin proteolysis by calpain and resulted in an increase in myotube adhesion.
Collapse
Affiliation(s)
- Fabrice Raynaud
- UMR5539, EPHE-CNRS-UM2, cc107, Université Montpellier II, place E. Bataillon, 34095 Montpellier cedex 5, France.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
8
|
Angeles DC, Song KP. Peptide antibiotic and actin-binding protein as mixed-type inhibitors of Clostridium difficile CDT toxin activities. Biochem Biophys Res Commun 2005; 327:361-70. [PMID: 15629471 DOI: 10.1016/j.bbrc.2004.11.167] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/18/2004] [Indexed: 11/30/2022]
Abstract
CDT from Clostridium difficile is an ADP-ribosyltransferase that causes rapid actin disaggregation and cell death. For efficient catalysis, CDT required specific divalent cations and binding by NAD which can be substituted by ATP but not ADP. Increasing isolation of CDT-producing strains prompted our search for antagonists like the anti-C. difficile agents bacitracin and vancomycin which were effective CDT inhibitors. Other CDT transferase and glycohydrolase inhibitors with consistently low IC50 values were heterocyclic peptide antibiotics containing modified amino acids such as polymyxin B and beta-lactam cephalosporins. The strongest inhibitors were actin-binding proteins which possess extensive interfaces with G-actin, adjoining the CDT-ADP-ribose+ acceptor site and nucleotide cleft. Analysis of the extent and mode of inhibition and actin interaction sites provided fresh evidences on the designation of actin interface domains with actin-binding proteins. Our results uphold ADP-ribosylation as an innate physiologic process in cellular cytoskeletal reorganization regulated by endogenous metabolites.
Collapse
Affiliation(s)
- Dario Cruz Angeles
- Microbial Pathogenesis Laboratory, Department of Microbiology, Faculty of Medicine, National University of Singapore, Singapore 117597, Singapore
| | | |
Collapse
|
9
|
Abstract
Spectrin family proteins represent an important group of actin-bundling and membrane-anchoring proteins found in diverse structures from yeast to man. Arising from a common ancestral alpha-actinin gene through duplications and rearrangements, the family has increased to include the spectrins and dystrophin/utrophin. The spectrin family is characterized by the presence of spectrin repeats, actin binding domains, and EF hands. With increasing divergence, new domains and functions have been added such that spectrin and dystrophin also contain specialized protein-protein interaction motifs and regions for interaction with membranes and phospholipids. The acquisition of new domains also increased the functional complexity of the family such that the proteins perform a range of tasks way beyond the simple bundling of actin filaments by alpha-actinin in S. pombe. We discuss the evolutionary, structural, functional, and regulatory roles of the spectrin family of proteins and describe some of the disease traits associated with loss of spectrin family protein function.
Collapse
Affiliation(s)
- M J F Broderick
- Department of Biomedical Science, University of Sheffield, Sheffield S10 2TN, United Kingdom
| | | |
Collapse
|
10
|
Lebart MC, Hubert F, Boiteau C, Ventéo S, Roustan C, Benyamin Y. Biochemical characterization of the L-plastin-actin interaction shows a resemblance with that of alpha-actinin and allows a distinction to be made between the two actin-binding domains of the molecule. Biochemistry 2004; 43:2428-37. [PMID: 14992580 DOI: 10.1021/bi030151p] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Actin interaction with L-plastin, a plastin/fimbrins isoform of the alpha-actinin family of molecules, is poorly characterized, from the biochemical point of view. Besides, molecular modeling of the T-isoform has recently provided a complete model of interaction with filamentous actin [Volkmann, N., DeRosier, D., Matsudaira, P., and Hanein, D. (2001) J. Cell Biol. 153, 947-956]. In this study, we report that recombinant L-plastin binds actin in a manner that strongly resembles that of the alpha-actinin-actin interface. The similitudes concern the absence of specificity toward the actin isoform and the inhibition of the binding by phosphoinositides. Furthermore, the participation of actin peptides 112-125 and 360-372 in the interface together with an inhibition of the rate of pyrenyl F-actin depolymerization is in favor of a lateral binding of the plastin isoform along the filament axis and strenghtens the similitudes in the way L-plastin and alpha-actinin bind to actin. We have also investigated the functional aspect and the putative equivalence of the two actin-binding domains of L-plastin toward actin binding. We demonstrate for the first time that the two recombinant fragments, expressed as single domains, have different affinities for actin. We further analyzed the difference using chemical cross-linking and F-actin depolymerization experiments assayed by fluorescence and high-speed centrifugation. The results clearly demonstrate that the two actin-binding domains of plastin display different modes of interaction with the actin filament. We discuss these results in light of the model of actin interaction proposed for T-plastin.
Collapse
Affiliation(s)
- M-C Lebart
- UMR 5539, Laboratoire de Motilité Cellulaire (EPHE), USTL, Bât.24, 4 étage, cc 107, place E. Bataillon, 34095 Montpellier, France.
| | | | | | | | | | | |
Collapse
|
11
|
Cohen G, Rubinstein S, Gur Y, Breitbart H. Crosstalk between protein kinase A and C regulates phospholipase D and F-actin formation during sperm capacitation. Dev Biol 2004; 267:230-41. [PMID: 14975729 DOI: 10.1016/j.ydbio.2003.10.034] [Citation(s) in RCA: 87] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2003] [Revised: 10/01/2003] [Accepted: 10/22/2003] [Indexed: 11/18/2022]
Abstract
Mammalian spermatozoa should reside in the female reproductive tract for a certain time before gaining the ability to fertilize. During this time, the spermatozoa undergo a series of biochemical processes collectively called capacitation. We recently demonstrated that actin polymerization is a necessary step in the cascade leading to capacitation. We demonstrate here for the first time a role for phospholipase D (PLD) in the induction of actin polymerization and capacitation in spermatozoa. The involvement of PLD is supported by specific inhibition of F-actin formation during sperm capacitation by PLD inhibitors and the stimulation of fast F-actin formation by exogenous PLD or phosphatidic acid (PA). Moreover, PLD activity is enhanced during capacitation before actin polymerization. Protein kinase A (PKA), known to be active in sperm capacitation, and protein kinase C (PKC), involved in the acrosome reaction, can both activate PLD and actin polymerization. We suggest that PKA- and PKC-dependent signal transduction pathways can potentially lead to PLD activation; however, under physiological conditions, actin polymerization depends primarily on PKA activity. Activation of PKA during capacitation causes inactivation of phospholipase C, and as a result, PKC activation is prevented. It appears that PKA activation promotes sperm capacitation whereas early activation of PKC during capacitation would jeopardize this process.
Collapse
Affiliation(s)
- G Cohen
- Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan 52900, Israel
| | | | | | | |
Collapse
|
12
|
Raynaud F, Bonnal C, Fernandez E, Bremaud L, Cerutti M, Lebart MC, Roustan C, Ouali A, Benyamin Y. The calpain 1-alpha-actinin interaction. Resting complex between the calcium-dependent protease and its target in cytoskeleton. ACTA ACUST UNITED AC 2004; 270:4662-70. [PMID: 14622253 DOI: 10.1046/j.1432-1033.2003.03859.x] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Calpain 1 behaviour toward cytoskeletal targets was investigated using two alpha-actinin isoforms from smooth and skeletal muscles. These two isoforms which are, respectively, sensitive and resistant to calpain cleavage, interact with the protease when using in vitro binding assays. The stability of the complexes in EGTA [Kd(-Ca2+) = 0.5 +/- 0.1 microM] was improved in the presence of 1 mm calcium ions [Kd(+Ca2+) = 0.05 +/- 0.01 microM]. Location of the binding structures shows that the C-terminal domain of alpha-actinin and each calpain subunit, 28 and 80 kDa, participates in the interaction. In particular, the autolysed calpain form (76/18) affords a similar binding compared to the 80/28 intact enzyme, with an identified binding site in the catalytic subunit, located in the C-terminal region of the chain (domain III-IV). The in vivo colocalization of calpain 1 and alpha-actinin was shown to be likely in the presence of calcium, when permeabilized muscle fibres were supplemented by exogenous calpain 1 and the presence of calpain 1 in Z-line cores was shown by gold-labelled antibodies. The demonstration of such a colocalization was brought by coimmunoprecipitation experiments of calpain 1 and alpha-actinin from C2.7 myogenic cells. We propose that calpain 1 interacts in a resting state with cytoskeletal targets, and that this binding is strengthened in pathological conditions, such as ischaemia and dystrophies, associated with high calcium concentrations.
Collapse
Affiliation(s)
- Fabrice Raynaud
- UMR 5539 - CNRS, laboratoire de Motilité Cellulaire - EPHE, cc107, USTL, Montpellier, France
| | | | | | | | | | | | | | | | | |
Collapse
|
13
|
Sparrow JC, Nowak KJ, Durling HJ, Beggs AH, Wallgren-Pettersson C, Romero N, Nonaka I, Laing NG. Muscle disease caused by mutations in the skeletal muscle alpha-actin gene (ACTA1). Neuromuscul Disord 2003; 13:519-31. [PMID: 12921789 DOI: 10.1016/s0960-8966(03)00101-9] [Citation(s) in RCA: 154] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
Mutations in the skeletal muscle alpha-actin gene (ACTA1) associated with congenital myopathy with excess of thin myofilaments, nemaline myopathy and intranuclear rod myopathy were first described in 1999. At that time, only 15 different missense mutations were known in ACTA1. More than 60 mutations have now been identified. This review analyses this larger spectrum of mutations in ACTA1. It investigates the molecular consequences of the mutations found to date, provides a framework for genotype-phenotype correlation and suggests future studies in light of results of investigation of normal and mutant actin in other systems, notably the actin specific to the indirect flight muscles of Drosophila. The larger series confirms that the majority of ACTA1 mutations are dominant, a small number are recessive and most isolated cases with no previous family history have de novo dominant mutations. The severity of the disease caused ranges from lack of spontaneous movements at birth requiring immediate mechanical ventilation, to mild disease compatible with life to adulthood. Overall, the mutations within ACTA1 are randomly distributed throughout the protein. However, the larger series of mutations now available indicates that there may be clustering of mutations associated with some phenotypes, e.g. actin myopathy. This would suggest that interference with certain actin functions may be more associated with certain phenotypes, though the exact pathophysiology of the actin mutations remains unknown.
Collapse
Affiliation(s)
- John C Sparrow
- Department of Biology, University of York, York, YO10 5DD, UK
| | | | | | | | | | | | | | | |
Collapse
|
14
|
König N, Raynaud F, Feane H, Durand M, Mestre-Francès N, Rossel M, Ouali A, Benyamin Y. Calpain 3 is expressed in astrocytes of rat and Microcebus brain. J Chem Neuroanat 2003; 25:129-36. [PMID: 12663060 DOI: 10.1016/s0891-0618(02)00102-3] [Citation(s) in RCA: 32] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
The calcium-dependent protease calpain is involved in numerous functions, including the control of cell survival, plasticity and motility. Whereas the isoforms calpain 1 and 2 have been described as ubiquitously expressed enzymes, calpain 3 has been called "muscle-specific", although trace amounts of calpain 3 mRNA have been detected by Northern blot in brain homogenates. In this study, we validated antibodies raised either against the peptides that were specific for a given isoform or the peptides present in all the three isoforms. We then used the anti-calpain 3 antibodies together with antibodies directed against cell-type-specific proteins to determine by double- and triple-labelling immunocytochemistry if the protease is expressed in specific cell populations of rat as well as lesser mouse lemur (Microcebus murinus) brain. Calpain 3 was almost exclusively found in cells displaying astrocyte morphology. These cells, most of which co-expressed glial fibrillary acidic protein, were particularly numerous close to the striatal subventricular zone (where numerous neurones forming the rostral migratory stream (RMS) towards the olfactory bulbs are generated) and the RMS itself. Other immunoreactive cells were found close to the pial surface of the forebrain, in the corpus callosum and in the dentate gyrus. Calpain 3 may be involved in astrocyte plasticity and/or motility.
Collapse
Affiliation(s)
- Norbert König
- EPHE Biologie Cellulaire Quantitative, INSERM EMI 12/Univ. Montpellier 2, CC 103, Place E. Bataillon, 34095 Montpellier Cedex 5, France.
| | | | | | | | | | | | | | | |
Collapse
|
15
|
Lee S, Park JB, Kim JH, Kim Y, Kim JH, Shin KJ, Lee JS, Ha SH, Suh PG, Ryu SH. Actin Directly Interacts with Phospholipase D, Inhibiting Its Activity. J Biol Chem 2001; 276:28252-60. [PMID: 11373276 DOI: 10.1074/jbc.m008521200] [Citation(s) in RCA: 90] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
Mammalian phospholipase D (PLD) plays a key role in several signal transduction pathways and is involved in many diverse functions. To elucidate the complex molecular regulation of PLD, we investigated PLD-binding proteins obtained from rat brain extract. Here we report that a 43-kDa protein in the rat brain, beta-actin, acts as a major PLD2 direct-binding protein as revealed by peptide mass fingerprinting in combination with matrix-assisted laser desorption ionization/time-of-flight mass spectrometry. We also determined that the region between amino acids 613 and 723 of PLD2 is required for the direct binding of beta-actin, using bacterially expressed glutathione S-transferase fusion proteins of PLD2 fragments. Intriguingly, purified beta-actin potently inhibited both phosphatidylinositol-4,5-bisphosphate- and oleate-dependent PLD2 activities in a concentration-dependent manner (IC50 = 5 nm). In a previous paper, we reported that alpha-actinin inhibited PLD2 activity in an interaction-dependent and an ADP-ribosylation factor 1 (ARF1)-reversible manner (Park, J. B., Kim, J. H., Kim, Y., Ha, S. H., Kim, J. H., Yoo, J.-S., Du, G., Frohman, M. A., Suh, P.-G., and Ryu, S. H. (2000) J. Biol. Chem. 275, 21295-21301). In vitro binding analyses showed that beta-actin could displace alpha-actinin binding to PLD2, demonstrating independent interaction between cytoskeletal proteins and PLD2. Furthermore, ARF1 could steer the PLD2 activity in a positive direction regardless of the inhibitory effect of beta-actin on PLD2. We also observed that beta-actin regulates PLD1 and PLD2 with similar binding and inhibitory potencies. Immunocytochemical and co-immunoprecipitation studies demonstrated the in vivo interaction between the two PLD isozymes and actin in cells. Taken together, these results suggest that the regulation of PLD by cytoskeletal proteins, beta-actin and alpha-actinin, and ARF1 may play an important role in cytoskeleton-related PLD functions.
Collapse
Affiliation(s)
- S Lee
- Division of Molecular and Life Sciences, Pohang University of Science and Technology, Pohang 790-784, Republic of Korea
| | | | | | | | | | | | | | | | | | | |
Collapse
|
16
|
Ilkovski B, Cooper ST, Nowak K, Ryan MM, Yang N, Schnell C, Durling HJ, Roddick LG, Wilkinson I, Kornberg AJ, Collins KJ, Wallace G, Gunning P, Hardeman EC, Laing NG, North KN. Nemaline myopathy caused by mutations in the muscle alpha-skeletal-actin gene. Am J Hum Genet 2001; 68:1333-43. [PMID: 11333380 PMCID: PMC1226120 DOI: 10.1086/320605] [Citation(s) in RCA: 114] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2001] [Accepted: 03/28/2001] [Indexed: 11/03/2022] Open
Abstract
Nemaline myopathy (NM) is a clinically and genetically heterogeneous disorder characterized by muscle weakness and the presence of nemaline bodies (rods) in skeletal muscle. Disease-causing mutations have been reported in five genes, each encoding a protein component of the sarcomeric thin filament. Recently, we identified mutations in the muscle alpha-skeletal-actin gene (ACTA1) in a subset of patients with NM. In the present study, we evaluated a new series of 35 patients with NM. We identified five novel missense mutations in ACTA1, which suggested that mutations in muscle alpha-skeletal actin account for the disease in approximately 15% of patients with NM. The mutations appeared de novo and represent new dominant mutations. One proband subsequently had two affected children, a result consistent with autosomal dominant transmission. The seven patients exhibited marked clinical variability, ranging from severe congenital-onset weakness, with death from respiratory failure during the 1st year of life, to a mild childhood-onset myopathy, with survival into adulthood. There was marked variation in both age at onset and clinical severity in the three affected members of one family. Common pathological features included abnormal fiber type differentiation, glycogen accumulation, myofibrillar disruption, and "whorling" of actin thin filaments. The percentage of fibers with rods did not correlate with clinical severity; however, the severe, lethal phenotype was associated with both severe, generalized disorganization of sarcomeric structure and abnormal localization of sarcomeric actin. The marked variability, in clinical phenotype, among patients with different mutations in ACTA1 suggests that both the site of the mutation and the nature of the amino acid change have differential effects on thin-filament formation and protein-protein interactions. The intrafamilial variability suggests that alpha-actin genotype is not the sole determinant of phenotype.
Collapse
MESH Headings
- Actins/chemistry
- Actins/genetics
- Adolescent
- Adult
- Amino Acid Sequence
- Australia
- Child
- Child, Preschool
- Cohort Studies
- DNA Mutational Analysis
- Female
- Humans
- Immunohistochemistry
- Infant
- Infant, Newborn
- Male
- Microscopy, Electron
- Middle Aged
- Models, Molecular
- Molecular Sequence Data
- Muscle, Skeletal/metabolism
- Muscle, Skeletal/pathology
- Muscle, Skeletal/physiopathology
- Muscle, Skeletal/ultrastructure
- Mutation, Missense/genetics
- Myopathies, Nemaline/genetics
- Myopathies, Nemaline/metabolism
- Myopathies, Nemaline/pathology
- Myopathies, Nemaline/physiopathology
- Phenotype
- Protein Conformation
- Protein Isoforms/chemistry
- Protein Isoforms/genetics
- RNA, Messenger/analysis
- RNA, Messenger/genetics
Collapse
Affiliation(s)
- Biljana Ilkovski
- The Institute for Neuromuscular Research and Oncology Research Unit, The Children’s Hospital at Westmead, Department of Paediatrics and Child Health, University of Sydney, and Muscle Development Unit, Children’s Medical Research Institute, Sydney; Centre for Neuromuscular and Neurological Disorders, University of Western Australia, Australian Neuromuscular Research Institute, Queen Elizabeth II Medical Centre, Nedlands, Western Australia; Division of Veterinary and Biomedical Sciences, Murdoch University, Murdoch, Western Australia; John Hunter Children’s Hospital, Newcastle, Australia; Department of Neurology, Children’s Neuroscience Centre, Royal Children’s Hospital, and Department of Neurology and Department of Child Development and Rehabilitation, Royal Children’s Hospital, Melbourne; and Mater Children’s Hospital, Raymond Terrace, South Brisbane, Australia
| | - Sandra T. Cooper
- The Institute for Neuromuscular Research and Oncology Research Unit, The Children’s Hospital at Westmead, Department of Paediatrics and Child Health, University of Sydney, and Muscle Development Unit, Children’s Medical Research Institute, Sydney; Centre for Neuromuscular and Neurological Disorders, University of Western Australia, Australian Neuromuscular Research Institute, Queen Elizabeth II Medical Centre, Nedlands, Western Australia; Division of Veterinary and Biomedical Sciences, Murdoch University, Murdoch, Western Australia; John Hunter Children’s Hospital, Newcastle, Australia; Department of Neurology, Children’s Neuroscience Centre, Royal Children’s Hospital, and Department of Neurology and Department of Child Development and Rehabilitation, Royal Children’s Hospital, Melbourne; and Mater Children’s Hospital, Raymond Terrace, South Brisbane, Australia
| | - Kristen Nowak
- The Institute for Neuromuscular Research and Oncology Research Unit, The Children’s Hospital at Westmead, Department of Paediatrics and Child Health, University of Sydney, and Muscle Development Unit, Children’s Medical Research Institute, Sydney; Centre for Neuromuscular and Neurological Disorders, University of Western Australia, Australian Neuromuscular Research Institute, Queen Elizabeth II Medical Centre, Nedlands, Western Australia; Division of Veterinary and Biomedical Sciences, Murdoch University, Murdoch, Western Australia; John Hunter Children’s Hospital, Newcastle, Australia; Department of Neurology, Children’s Neuroscience Centre, Royal Children’s Hospital, and Department of Neurology and Department of Child Development and Rehabilitation, Royal Children’s Hospital, Melbourne; and Mater Children’s Hospital, Raymond Terrace, South Brisbane, Australia
| | - Monique M. Ryan
- The Institute for Neuromuscular Research and Oncology Research Unit, The Children’s Hospital at Westmead, Department of Paediatrics and Child Health, University of Sydney, and Muscle Development Unit, Children’s Medical Research Institute, Sydney; Centre for Neuromuscular and Neurological Disorders, University of Western Australia, Australian Neuromuscular Research Institute, Queen Elizabeth II Medical Centre, Nedlands, Western Australia; Division of Veterinary and Biomedical Sciences, Murdoch University, Murdoch, Western Australia; John Hunter Children’s Hospital, Newcastle, Australia; Department of Neurology, Children’s Neuroscience Centre, Royal Children’s Hospital, and Department of Neurology and Department of Child Development and Rehabilitation, Royal Children’s Hospital, Melbourne; and Mater Children’s Hospital, Raymond Terrace, South Brisbane, Australia
| | - Nan Yang
- The Institute for Neuromuscular Research and Oncology Research Unit, The Children’s Hospital at Westmead, Department of Paediatrics and Child Health, University of Sydney, and Muscle Development Unit, Children’s Medical Research Institute, Sydney; Centre for Neuromuscular and Neurological Disorders, University of Western Australia, Australian Neuromuscular Research Institute, Queen Elizabeth II Medical Centre, Nedlands, Western Australia; Division of Veterinary and Biomedical Sciences, Murdoch University, Murdoch, Western Australia; John Hunter Children’s Hospital, Newcastle, Australia; Department of Neurology, Children’s Neuroscience Centre, Royal Children’s Hospital, and Department of Neurology and Department of Child Development and Rehabilitation, Royal Children’s Hospital, Melbourne; and Mater Children’s Hospital, Raymond Terrace, South Brisbane, Australia
| | - Christina Schnell
- The Institute for Neuromuscular Research and Oncology Research Unit, The Children’s Hospital at Westmead, Department of Paediatrics and Child Health, University of Sydney, and Muscle Development Unit, Children’s Medical Research Institute, Sydney; Centre for Neuromuscular and Neurological Disorders, University of Western Australia, Australian Neuromuscular Research Institute, Queen Elizabeth II Medical Centre, Nedlands, Western Australia; Division of Veterinary and Biomedical Sciences, Murdoch University, Murdoch, Western Australia; John Hunter Children’s Hospital, Newcastle, Australia; Department of Neurology, Children’s Neuroscience Centre, Royal Children’s Hospital, and Department of Neurology and Department of Child Development and Rehabilitation, Royal Children’s Hospital, Melbourne; and Mater Children’s Hospital, Raymond Terrace, South Brisbane, Australia
| | - Hayley J. Durling
- The Institute for Neuromuscular Research and Oncology Research Unit, The Children’s Hospital at Westmead, Department of Paediatrics and Child Health, University of Sydney, and Muscle Development Unit, Children’s Medical Research Institute, Sydney; Centre for Neuromuscular and Neurological Disorders, University of Western Australia, Australian Neuromuscular Research Institute, Queen Elizabeth II Medical Centre, Nedlands, Western Australia; Division of Veterinary and Biomedical Sciences, Murdoch University, Murdoch, Western Australia; John Hunter Children’s Hospital, Newcastle, Australia; Department of Neurology, Children’s Neuroscience Centre, Royal Children’s Hospital, and Department of Neurology and Department of Child Development and Rehabilitation, Royal Children’s Hospital, Melbourne; and Mater Children’s Hospital, Raymond Terrace, South Brisbane, Australia
| | - Laurence G. Roddick
- The Institute for Neuromuscular Research and Oncology Research Unit, The Children’s Hospital at Westmead, Department of Paediatrics and Child Health, University of Sydney, and Muscle Development Unit, Children’s Medical Research Institute, Sydney; Centre for Neuromuscular and Neurological Disorders, University of Western Australia, Australian Neuromuscular Research Institute, Queen Elizabeth II Medical Centre, Nedlands, Western Australia; Division of Veterinary and Biomedical Sciences, Murdoch University, Murdoch, Western Australia; John Hunter Children’s Hospital, Newcastle, Australia; Department of Neurology, Children’s Neuroscience Centre, Royal Children’s Hospital, and Department of Neurology and Department of Child Development and Rehabilitation, Royal Children’s Hospital, Melbourne; and Mater Children’s Hospital, Raymond Terrace, South Brisbane, Australia
| | - Ian Wilkinson
- The Institute for Neuromuscular Research and Oncology Research Unit, The Children’s Hospital at Westmead, Department of Paediatrics and Child Health, University of Sydney, and Muscle Development Unit, Children’s Medical Research Institute, Sydney; Centre for Neuromuscular and Neurological Disorders, University of Western Australia, Australian Neuromuscular Research Institute, Queen Elizabeth II Medical Centre, Nedlands, Western Australia; Division of Veterinary and Biomedical Sciences, Murdoch University, Murdoch, Western Australia; John Hunter Children’s Hospital, Newcastle, Australia; Department of Neurology, Children’s Neuroscience Centre, Royal Children’s Hospital, and Department of Neurology and Department of Child Development and Rehabilitation, Royal Children’s Hospital, Melbourne; and Mater Children’s Hospital, Raymond Terrace, South Brisbane, Australia
| | - Andrew J. Kornberg
- The Institute for Neuromuscular Research and Oncology Research Unit, The Children’s Hospital at Westmead, Department of Paediatrics and Child Health, University of Sydney, and Muscle Development Unit, Children’s Medical Research Institute, Sydney; Centre for Neuromuscular and Neurological Disorders, University of Western Australia, Australian Neuromuscular Research Institute, Queen Elizabeth II Medical Centre, Nedlands, Western Australia; Division of Veterinary and Biomedical Sciences, Murdoch University, Murdoch, Western Australia; John Hunter Children’s Hospital, Newcastle, Australia; Department of Neurology, Children’s Neuroscience Centre, Royal Children’s Hospital, and Department of Neurology and Department of Child Development and Rehabilitation, Royal Children’s Hospital, Melbourne; and Mater Children’s Hospital, Raymond Terrace, South Brisbane, Australia
| | - Kevin J. Collins
- The Institute for Neuromuscular Research and Oncology Research Unit, The Children’s Hospital at Westmead, Department of Paediatrics and Child Health, University of Sydney, and Muscle Development Unit, Children’s Medical Research Institute, Sydney; Centre for Neuromuscular and Neurological Disorders, University of Western Australia, Australian Neuromuscular Research Institute, Queen Elizabeth II Medical Centre, Nedlands, Western Australia; Division of Veterinary and Biomedical Sciences, Murdoch University, Murdoch, Western Australia; John Hunter Children’s Hospital, Newcastle, Australia; Department of Neurology, Children’s Neuroscience Centre, Royal Children’s Hospital, and Department of Neurology and Department of Child Development and Rehabilitation, Royal Children’s Hospital, Melbourne; and Mater Children’s Hospital, Raymond Terrace, South Brisbane, Australia
| | - Geoff Wallace
- The Institute for Neuromuscular Research and Oncology Research Unit, The Children’s Hospital at Westmead, Department of Paediatrics and Child Health, University of Sydney, and Muscle Development Unit, Children’s Medical Research Institute, Sydney; Centre for Neuromuscular and Neurological Disorders, University of Western Australia, Australian Neuromuscular Research Institute, Queen Elizabeth II Medical Centre, Nedlands, Western Australia; Division of Veterinary and Biomedical Sciences, Murdoch University, Murdoch, Western Australia; John Hunter Children’s Hospital, Newcastle, Australia; Department of Neurology, Children’s Neuroscience Centre, Royal Children’s Hospital, and Department of Neurology and Department of Child Development and Rehabilitation, Royal Children’s Hospital, Melbourne; and Mater Children’s Hospital, Raymond Terrace, South Brisbane, Australia
| | - Peter Gunning
- The Institute for Neuromuscular Research and Oncology Research Unit, The Children’s Hospital at Westmead, Department of Paediatrics and Child Health, University of Sydney, and Muscle Development Unit, Children’s Medical Research Institute, Sydney; Centre for Neuromuscular and Neurological Disorders, University of Western Australia, Australian Neuromuscular Research Institute, Queen Elizabeth II Medical Centre, Nedlands, Western Australia; Division of Veterinary and Biomedical Sciences, Murdoch University, Murdoch, Western Australia; John Hunter Children’s Hospital, Newcastle, Australia; Department of Neurology, Children’s Neuroscience Centre, Royal Children’s Hospital, and Department of Neurology and Department of Child Development and Rehabilitation, Royal Children’s Hospital, Melbourne; and Mater Children’s Hospital, Raymond Terrace, South Brisbane, Australia
| | - Edna C. Hardeman
- The Institute for Neuromuscular Research and Oncology Research Unit, The Children’s Hospital at Westmead, Department of Paediatrics and Child Health, University of Sydney, and Muscle Development Unit, Children’s Medical Research Institute, Sydney; Centre for Neuromuscular and Neurological Disorders, University of Western Australia, Australian Neuromuscular Research Institute, Queen Elizabeth II Medical Centre, Nedlands, Western Australia; Division of Veterinary and Biomedical Sciences, Murdoch University, Murdoch, Western Australia; John Hunter Children’s Hospital, Newcastle, Australia; Department of Neurology, Children’s Neuroscience Centre, Royal Children’s Hospital, and Department of Neurology and Department of Child Development and Rehabilitation, Royal Children’s Hospital, Melbourne; and Mater Children’s Hospital, Raymond Terrace, South Brisbane, Australia
| | - Nigel G. Laing
- The Institute for Neuromuscular Research and Oncology Research Unit, The Children’s Hospital at Westmead, Department of Paediatrics and Child Health, University of Sydney, and Muscle Development Unit, Children’s Medical Research Institute, Sydney; Centre for Neuromuscular and Neurological Disorders, University of Western Australia, Australian Neuromuscular Research Institute, Queen Elizabeth II Medical Centre, Nedlands, Western Australia; Division of Veterinary and Biomedical Sciences, Murdoch University, Murdoch, Western Australia; John Hunter Children’s Hospital, Newcastle, Australia; Department of Neurology, Children’s Neuroscience Centre, Royal Children’s Hospital, and Department of Neurology and Department of Child Development and Rehabilitation, Royal Children’s Hospital, Melbourne; and Mater Children’s Hospital, Raymond Terrace, South Brisbane, Australia
| | - Kathryn N. North
- The Institute for Neuromuscular Research and Oncology Research Unit, The Children’s Hospital at Westmead, Department of Paediatrics and Child Health, University of Sydney, and Muscle Development Unit, Children’s Medical Research Institute, Sydney; Centre for Neuromuscular and Neurological Disorders, University of Western Australia, Australian Neuromuscular Research Institute, Queen Elizabeth II Medical Centre, Nedlands, Western Australia; Division of Veterinary and Biomedical Sciences, Murdoch University, Murdoch, Western Australia; John Hunter Children’s Hospital, Newcastle, Australia; Department of Neurology, Children’s Neuroscience Centre, Royal Children’s Hospital, and Department of Neurology and Department of Child Development and Rehabilitation, Royal Children’s Hospital, Melbourne; and Mater Children’s Hospital, Raymond Terrace, South Brisbane, Australia
| |
Collapse
|
17
|
Kwiateck O, Papa I, Lebart MC, Benyamin Y, Roustan C. Interaction of actin with the capping protein, CapZ from sea bass (Dicentrarchus labrax) white skeletal muscle. Comp Biochem Physiol B Biochem Mol Biol 2000; 127:551-62. [PMID: 11281272 DOI: 10.1016/s0305-0491(00)00289-3] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Abstract
We have compared the functional properties of CapZ from fish white skeletal muscle with those of CapZ from chicken muscle. CapZ is a heterodimer, which enhances actin nucleation and inhibits the depolymerization process by binding to the barbed ends of microfilaments. Here, we report the interaction of CapZ not only with F-actin, but also with monomeric actin. The affinity of sea bass CapZ for G-actin estimated by enzyme-linked immunosorbent assay (ELISA) was in the microM range. This association was PIP2 dependent. Binding contacts with the barbed end of actin were delimited by both ELISA and fluorescence approaches. One site (actin sequence 338-348) was located in a helical region of the subdomain 1, region already implicated in the interaction with other actin binding proteins such as gelsolin. Another site implicates the C-terminal region (sequence 360-372) of actin. Finally, the partial competition of antibodies directed against CapZ alpha or beta-subunits towards CapZ interaction with actin filaments suggests both subunits participate in the complex with actin.
Collapse
Affiliation(s)
- O Kwiateck
- UMR 5539 CNRS, Laboratoire de Recherche sur la Motilité Cellulaire EPHE, Université de Montpellier, France
| | | | | | | | | |
Collapse
|
18
|
Bellanger JM, Astier C, Sardet C, Ohta Y, Stossel TP, Debant A. The Rac1- and RhoG-specific GEF domain of Trio targets filamin to remodel cytoskeletal actin. Nat Cell Biol 2000; 2:888-92. [PMID: 11146652 DOI: 10.1038/35046533] [Citation(s) in RCA: 172] [Impact Index Per Article: 7.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Rho GTPases control actin reorganization and many other cellular functions. Guanine nucleotide-exchange factors (GEFs) activate Rho GTPases by promoting their exchange of GDP for GTP. Trio is a unique Rho GEF, because it has separate GEF domains, GEFD1 and GEFD2, that control the GTPases RhoG/Rac1 and RhoA, respectively. Dbl-homology (DH) domains that are common to GEFs catalyse nucleotide exchange, and pleckstrin-homology (PH) domains localize Rho GEFs near their downstream targets. Here we show that Trio GEFD1 interacts through its PH domain with the actin-filament-crosslinking protein filamin, and localizes with endogenous filamin in HeLa cells. Trio GEFD1 induces actin-based ruffling in filamin-expressing, but not filamin-deficient, cells and in cells transfected with a filamin construct that lacks the Trio-binding domain. In addition, Trio GEFD1 exchange activity is not affected by filamin binding. Our results indicate that filamin, as a molecular target of Trio, may be a scaffold for the spatial organization of Rho-GTPase-mediated signalling pathways.
Collapse
Affiliation(s)
- J M Bellanger
- CRBM-CNRS, UPR 1086, 1919 Route de Mende, 34293 Montpellier Cédex 5, France
| | | | | | | | | | | |
Collapse
|
19
|
Christerson LB, Vanderbilt CA, Cobb MH. MEKK1 interacts with alpha-actinin and localizes to stress fibers and focal adhesions. CELL MOTILITY AND THE CYTOSKELETON 2000; 43:186-98. [PMID: 10401575 DOI: 10.1002/(sici)1097-0169(1999)43:3<186::aid-cm2>3.0.co;2-1] [Citation(s) in RCA: 83] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
Mitogen-activated protein (MAP) kinases orchestrate the effects of many extracellular stimuli on cells. The serine/threonine protein kinase MEKK1 is an upstream activator of the MAP kinases c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK), extracellular signal-regulated kinase (ERK), and p38 as well as NF-kappa B. In a yeast two-hybrid interaction screen to identify proteins that bind to an N-terminal fragment of MEKK1 (amino acids 1-719), the actin-crosslinking protein alpha-actinin was identified as a MEKK1-binding protein. Over-expressed MEKK1 co-immunoprecipitated with alpha-actinin in cell lysates. Both endogenous and over-expressed MEKK1 colocalized with alpha-actinin along actin stress fibers and at focal adhesions. Residues 221-559 of MEKK1 bound to purified alpha-actinin in vitro, indicating that the interaction is direct, and this fragment localized to actin filaments in cells. MEKK1 kinase activity was not required for association with actin filaments, because a catalytically inactive mutant of MEKK1 (MEKK1 D1369A) localized to stress fibers. These results provide strong evidence for the interaction between MEKK1 and alpha-actinin. Thus, restriction of the kinase to the actin cytoskeleton may serve to regulate its specificity towards downstream targets.
Collapse
Affiliation(s)
- L B Christerson
- Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas 75235, USA
| | | | | |
Collapse
|
20
|
Keep NH, Winder SJ, Moores CA, Walke S, Norwood FL, Kendrick-Jones J. Crystal structure of the actin-binding region of utrophin reveals a head-to-tail dimer. Structure 1999; 7:1539-46. [PMID: 10647184 DOI: 10.1016/s0969-2126(00)88344-6] [Citation(s) in RCA: 80] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Abstract
BACKGROUND Utrophin is a large multidomain protein that belongs to a superfamily of actin-binding proteins, which includes dystrophin, alpha-actinin, beta-spectrin, fimbrin, filamin and plectin. All the members of this family contain a common actin-binding region at their N termini and perform a wide variety of roles associated with the actin cytoskeleton. Utrophin is the autosomal homologue of dystrophin, the protein defective in the X-linked Duchenne and Becker muscular dystrophies, and upregulation of utrophin has been suggested as a potential therapy for muscular dystrophy patients. RESULTS The structure of the actin-binding region of utrophin, consisting of two calponin-homology (CH) domains, has been solved at 3.0 A resolution. It is composed of an antiparallel dimer with each of the monomers being present in an extended dumbell shape and the two CH domains being separated by a long central helix. This extended conformation is in sharp contrast to the compact monomer structure of the N-terminal actin-binding region of fimbrin. CONCLUSIONS The crystal structure of the actin-binding region of utrophin suggests that these actin-binding domains may be more flexible than was previously thought and that this flexibility may allow domain reorganisation and play a role in the actin-binding mechanism. Thus utrophin could possibly bind to actin in an extended conformation so that the sites previously identified as being important for actin binding may be directly involved in this interaction.
Collapse
Affiliation(s)
- N H Keep
- MRC Laboratory of Molecular Biology, Cambridge, UK.
| | | | | | | | | | | |
Collapse
|
21
|
Leinweber B, Tang JX, Stafford WF, Chalovich JM. Calponin interaction with alpha-actinin-actin: evidence for a structural role for calponin. Biophys J 1999; 77:3208-17. [PMID: 10585942 PMCID: PMC1289132 DOI: 10.1016/s0006-3495(99)77151-1] [Citation(s) in RCA: 32] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023] Open
Abstract
The purpose of this study was to address the paradox of calponin localization with alpha-actinin and filamin, two proteins with tandem calponin homology (CH) domains, by determining the effect of these proteins on the binding of calponin to actin. The results show that actin can accommodate near-saturating concentrations of either calponin and alpha-actinin or calponin and filamin with little change or no change in ligand affinity. Little direct interaction occurred between alpha-actinin and calponin in the absence of actin, so this effect is not likely to explain the co-distribution of these proteins. Calponin, like alpha-actinin, induced elastic gel formation when added to actin. When alpha-actinin was added to newly formed calponin/actin gels, no change was seen in the mechanical properties of the gel compared to calponin and actin alone. However, when calponin was added to newly formed alpha-actinin/actin gels, the resulting gel was much stronger than the gels formed by either ligand alone. Furthermore, gels formed by the addition of calponin to alpha-actinin/actin exhibited a phenomenon known as strain hardening, a characteristic of mechanically resilient gels. These results add weight to the concept that one of the functions of calponin is to stabilize the actin cytoskeleton.
Collapse
Affiliation(s)
- B Leinweber
- Department of Physiology, East Carolina University School of Medicine, Greenville, North Carolina 27834, USA
| | | | | | | |
Collapse
|
22
|
Renoult C, Ternent D, Maciver SK, Fattoum A, Astier C, Benyamin Y, Roustan C. The identification of a second cofilin binding site on actin suggests a novel, intercalated arrangement of F-actin binding. J Biol Chem 1999; 274:28893-9. [PMID: 10506133 DOI: 10.1074/jbc.274.41.28893] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
The cofilins are members of a protein family that binds monomeric and filamentous actin, severs actin filaments, and increases monomer off-rate from the pointed end. Here, we characterize the cofilin-actin interface. We confirm earlier work suggesting the importance of the lower region of subdomain 1 encompassing the N and C termini (site 1) in cofilin binding. In addition, we report the discovery of a new cofilin binding site (site 2) from residues 112-125 that form a helix toward the upper, rear surface of subdomain 1 in the standard actin orientation (Kabsch, W., Mannherz, H. G., Suck, D., Pai, E. F., and Holmes, K. C. (1990) Nature 347, 37-44). We propose that cofilin binds "behind" one monomer and "in front" of the other longitudinally associated monomer, accounting for the fact that cofilin alters the twist in the actin (McGough, A., Pope, B., Chiu, W., and Weeds, A. (1997) J. Cell Biol. 138, 771-781). The characterization of the cofilin-actin interface will facilitate an understanding of how cofilin severs and depolymerizes filaments and may shed light on the mechanism of the gelsolin family because they share a similar fold with the cofilins (Hatanaka, H., Ogura, K., Moriyama, K., Ichikawa, S., Yahara, I., and Inagiki, F. (1996) Cell 85, 1047-1055).
Collapse
Affiliation(s)
- C Renoult
- UMR 5539 (CNRS), Laboratoire de Motilité Cellulaire (Ecole Pratique des Hautes Etudes), Université de Montpellier 2, Place E. Bataillon, CC107, 34095 Montpellier Cedex 5, France
| | | | | | | | | | | | | |
Collapse
|
23
|
Volkmann N, Hanein D. Quantitative fitting of atomic models into observed densities derived by electron microscopy. J Struct Biol 1999; 125:176-84. [PMID: 10222273 DOI: 10.1006/jsbi.1998.4074] [Citation(s) in RCA: 175] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
A new methodology for fitting atomic models into density distributions is described. This approach is based on a global density correlation analysis that can be optionally supplemented by biochemical as well as biophysical data. The procedure is completely general and enables an objective evaluation of the resulting docking in the light of available biochemical and biophysical information as well as density correlation alone. In this paper we describe the implementation of the algorithm and its application to two biological systems. In both cases the procedure provided an interface model on the atomic level and located parts of the structure that were missing in the atomic model but present in the electron-microscopic construct. It also detected and quantified conformational changes in actomyosin complexes.
Collapse
Affiliation(s)
- N Volkmann
- Brandeis University, MS029, Waltham, Massachusetts 02254, USA.
| | | |
Collapse
|
24
|
Hanein D, Volkmann N, Goldsmith S, Michon AM, Lehman W, Craig R, DeRosier D, Almo S, Matsudaira P. An atomic model of fimbrin binding to F-actin and its implications for filament crosslinking and regulation. NATURE STRUCTURAL BIOLOGY 1998; 5:787-92. [PMID: 9731773 DOI: 10.1038/1828] [Citation(s) in RCA: 107] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
Using a new procedure that combines electron-density correlation with biochemical information, we have fitted the crystal structure of the N-terminal actin-binding domain of human T-fimbrin to helical reconstructions of fimbrin-decorated actin filaments. The map locates the N-terminal calcium-binding domain and identifies actin-binding site residues on the two calponin-homology domains of fimbrin. Based on this map, we propose a model of a fimbrin crosslink in an actin bundle and its regulation by calcium.
Collapse
Affiliation(s)
- D Hanein
- The W.M. Keck Institute for Cellular Visualization, Brandeis University, Waltham, Massachusetts 02254, USA.
| | | | | | | | | | | | | | | | | |
Collapse
|
25
|
Usmanova A, Astier C, Méjean C, Hubert F, Feinberg J, Benyamin Y, Roustan C. Coevolution of actin and associated proteins: an alpha-actinin-like protein in a cyanobacterium (Spirulina platensis). Comp Biochem Physiol B Biochem Mol Biol 1998; 120:693-700. [PMID: 9854817 DOI: 10.1016/s0305-0491(98)10065-2] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Actin, together with associated proteins, such as myosin, cross-linking or capping proteins, has been observed in all eukaryotic cells. Presence of actin or actin-like proteins has also been reported in prokaryotic organisms belonging to the cyanobacteria. Our aim was first to extend the characterization of an actin-like protein to another prokaryotic cell, i.e. Spirulina, then to compare the antigenic reactivity of this new protein with that of Synechocystis and skeletal actins. We observed that some of the conserved antigenic epitopes corresponded to actin regions known to interact with cross-linking proteins. We also report for the first time that alpha-actinin and filamin purified from chicken gizzard both interact with a prokaryotic actin-like protein. Finally, we searched for the occurrence of a cross-linking protein in these cyanobacteria and identified a 105-kDa protein as an alpha-actinin-like protein using specific antibodies.
Collapse
Affiliation(s)
- A Usmanova
- UMR 5539 (CNRS), Université de Montpellier 2, France
| | | | | | | | | | | | | |
Collapse
|
26
|
Hanein D, Matsudaira P, DeRosier DJ. Evidence for a conformational change in actin induced by fimbrin (N375) binding. J Cell Biol 1997; 139:387-96. [PMID: 9334343 PMCID: PMC2139807 DOI: 10.1083/jcb.139.2.387] [Citation(s) in RCA: 92] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/04/1996] [Revised: 08/06/1997] [Indexed: 02/05/2023] Open
Abstract
Fimbrin belongs to a superfamily of actin cross-linking proteins that share a conserved 27-kD actin-binding domain. This domain contains a tandem duplication of a sequence that is homologous to calponin. Calponin homology (CH) domains not only cross-link actin filaments into bundles and networks, but they also bind intermediate filaments and some signal transduction proteins to the actin cytoskeleton. This fundamental role of CH domains as a widely used actin-binding domain underlines the necessity to understand their structural interaction with actin. Using electron cryomicroscopy, we have determined the three-dimensional structure of F-actin and F-actin decorated with the NH2-terminal CH domains of fimbrin (N375). In a difference map between actin filaments and N375-decorated actin, one end of N375 is bound to a concave surface formed between actin subdomains 1 and 2 on two neighboring actin monomers. In addition, a fit of the atomic model for the actin filament to the maps reveals the actin residues that line, the binding surface. The binding of N375 changes actin, which we interpret as a movement of subdomain 1 away from the bound N375. This change in actin structure may affect its affinity for other actin-binding proteins and may be part of the regulation of the cytoskeleton itself. Difference maps between actin and actin decorated with other proteins provides a way to look for novel structural changes in actin.
Collapse
Affiliation(s)
- D Hanein
- The W.M. Keck Institute for Cellular Visualization and The Rosenstiel Basic Medical Sciences Research Center, Department of Biology, Brandeis University, Waltham, Massachusetts 02254, USA
| | | | | |
Collapse
|
27
|
|
28
|
Feinberg J, Mery J, Heitz F, Benyamin Y, Roustan C. Conformational and functional studies of three gelsolin subdomain-1 synthetic peptides and their implication in actin polymerization. Biopolymers 1997; 41:647-55. [PMID: 9108732 DOI: 10.1002/(sici)1097-0282(199705)41:6<647::aid-bip5>3.0.co;2-q] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
Gelsolin, a calcium and inositol phospholipid-sensitive protein, regulates actin filament length. Its activity is complex (capping, severing, etc.) and is supported by several functional domains. The N-terminal domain alone (S1), in particular, is able to impede actin polymerization. Our investigations were attempted to precise this inhibitory process by using synthetic peptides as models mimicking gelsolin S1 activity. Three peptides issued from S1 and located in gelsolin-actin interfaces were synthesized. The peptides (15-28, 42-55, and 96-114 sequences) were tested for their conformational and actin binding properties. Although the three peptides interact well with actin, only peptide 42-55 affects actin polymerization. A detailed kinetic study shows that the latter peptide essentially inhibits the nucleation step during actin polymerization. In conclusion, the present work shows that the binding of a synthetic peptide to a small sequence located outside the actin-actin interface is essential in the actin polymerization process.
Collapse
Affiliation(s)
- J Feinberg
- Centre de Recherches de Biochimie Macromoléculaire (CNRS), U.249 (INSERM), Université de Montpellier 1
| | | | | | | | | |
Collapse
|
29
|
Feinberg J, Lebart M, Benyamin Y, Roustan C. Localization of a calcium sensitive binding site for gelsolin on actin subdomain I: implication for severing process. Biochem Biophys Res Commun 1997; 233:61-5. [PMID: 9144396 DOI: 10.1006/bbrc.1997.6402] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
The binding of the N-terminal domain (S1) of gelsolin to monomeric actin has been extensively documented. In contrast, the location of the C-terminal calcium dependent domains (S4-6) interacting with the actin filament during the severing process remains uncertain. In this study, we have identified a new interface that supports calcium dependent gelsolin binding to actin. This site is located in a critical position towards actin-actin contact in the filament and in the vicinity of the phalloidin site. Using specific antibody and synthetic peptides derived from actin sequence within 105-132 residues, this interface was finally ascribed to the segment 112-120 on the actin subdomain-1.
Collapse
Affiliation(s)
- J Feinberg
- Centre de Recherches de Biochimie Macromoléculaire (CNRS), Laboratoirede Recherche sur la Motilité Cellulaire (Ecole Pratique des Hautes Etudes), Université de Montpellier 1, France
| | | | | | | |
Collapse
|
30
|
Schutt CE, Kreatsoulas C, Page R, Lindberg U. Plugging into actin's architectonic socket. NATURE STRUCTURAL BIOLOGY 1997; 4:169-72. [PMID: 9164452 DOI: 10.1038/nsb0397-169] [Citation(s) in RCA: 20] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
|
31
|
Meyer SC, Zuerbig S, Cunningham CC, Hartwig JH, Bissell T, Gardner K, Fox JE. Identification of the region in actin-binding protein that binds to the cytoplasmic domain of glycoprotein IBalpha. J Biol Chem 1997; 272:2914-9. [PMID: 9006936 DOI: 10.1074/jbc.272.5.2914] [Citation(s) in RCA: 71] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023] Open
Abstract
Actin-binding protein (ABP-280) is a component of the submembranous cytoskeleton and interacts with the glycoprotein (GP) Ibalpha subunit of the GP Ib-IX complex in platelets. In the present studies, we have identified the binding site for GP Ibalpha in ABP-280. A melanoma cell line lacking ABP-280 was stably transfected with the cDNAs coding for GP Ib-IX, then transiently transfected with cDNA coding for various carboxyl-truncates of ABP-280. Immunocapture assays and co-immunoprecipitation experiments from detergent-lysed cells showed that deletion of the carboxyl-terminal repeats 20-24 of ABP-280 had no effect on GP Ib-IX binding, but deletion of residues 2099 through 2136 within repeat 19 abolished binding. In the yeast two-hybrid system, an ABP-280 fragment comprising repeats 17-19 bound GP Ibalpha. Deletion from either end abolished binding. Individual or multiple repeats of ABP-280 were expressed as fusion protein in bacteria and purified; structural folding was evaluated, and binding to GP Ib-IX was assessed. Binding depended on the presence of repeats 17-19. None of the individual repeats were able to bind to GP Ib-IX. These findings demonstrate that residues 1850-2136 comprising repeats 17-19 contain the binding site for GP Ib-IX.
Collapse
Affiliation(s)
- S C Meyer
- Joseph J. Jacobs Center for Thrombosis and Vascular Biology, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
| | | | | | | | | | | | | |
Collapse
|
32
|
Abstract
Three of the most important questions concerning actin function are: (a) How does actin structure relate to actin function? (b) How does each of the numerous proteins that interact with actin contribute to actin cytoskeleton function in vivo? (c) How are the activities of these proteins regulated? Powerful molecular genetics combined with well-established biochemical techniques make the yeast Saccharomyces cerevisiae an ideal organism for studies aimed at answering these questions. The protein sequences and biochemical properties of actin and its interacting proteins and the pathways that regulate these interactions all appear to be conserved, indicating that principles elucidated from studies in yeast will apply to all eukaryotes. In this review, we highlight advances in our general understanding of actin properties, interactions with other proteins, and regulation of the actin cytoskeleton, derived from studies in the budding yeast S. cerevisiae.
Collapse
Affiliation(s)
- K R Ayscough
- Department of Molecular and Cell Biology, University of California, Berkeley 94720-3202, USA
| | | |
Collapse
|
33
|
Miyata H, Yasuda R, Kinosita K. Strength and lifetime of the bond between actin and skeletal muscle alpha-actinin studied with an optical trapping technique. BIOCHIMICA ET BIOPHYSICA ACTA 1996; 1290:83-8. [PMID: 8645711 DOI: 10.1016/0304-4165(96)00003-7] [Citation(s) in RCA: 63] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Abstract
The force required to break the bond between skeletal muscle actin and alpha-actinin (unbinding force) was measured at the level of individual molecules with an optical trapping technique. An actin filament, to the barbed-end of which was attached a gelsolin-coated polystyrene bead, was bound to alpha-actinin molecules adsorbed to a nitrocellulose-coated glass surface (approximately equal to 1 alpha-actinin molecule per 1 micron actin filament). The filament-bound bead was held by the optical trap and the force was applied to break the bond by pulling the bead. The unbinding force ranged from 1.4 to 44 pN. The average magnitude of the force was approximately equal to 18 pN. As the probability of the bond breakage has been suggested to be governed by the magnitude of the external force, the relationship was studied between the magnitude of the unbinding force and the time required to break the bond (unbinding time). The unbinding time ranged from approximately equal to 0.1 to approximately equal to 20 seconds, and tended to become shorter as the unbinding force became larger. The unbinding time seemed to be classifiable into two major groups: one group having a time value of 1 sec or less and the other having a time value ranging from several to 20 seconds. This suggests the existence of at least two classes of the actin-actinin bonds.
Collapse
Affiliation(s)
- H Miyata
- Department of Physics, Faculty of Science and Technology, Keio University, Yokohama, Japan.
| | | | | |
Collapse
|
34
|
Kuhlman PA, Hughes CA, Bennett V, Fowler VM. A new function for adducin. Calcium/calmodulin-regulated capping of the barbed ends of actin filaments. J Biol Chem 1996; 271:7986-91. [PMID: 8626479 DOI: 10.1074/jbc.271.14.7986] [Citation(s) in RCA: 164] [Impact Index Per Article: 5.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023] Open
Abstract
Adducin is a membrane skeleton protein originally described in human erythrocytes that promotes the binding of spectrin to actin and also binds directly to actin and bundles actin filaments. Adducin is associated with regions of cell-cell contact in nonerythroid cells, where it is believed to play a role in regulating the assembly of the spectrin-actin membrane skeleton. In this study we demonstrate a novel function for adducin; it completely blocks elongation and depolymerization at the barbed (fast growing) ends of actin filaments, thus functioning as a barbed end capping protein (Kcap approximately 100 nM). This barbed end capping activity requires the intact adducin molecule and is not provided by the NH2-terminal globular head domains alone nor by the COOH-terminal extended tail domains, which were previously shown to contain the spectrin-actin binding, calmodulin binding, and phosphorylation sites. A novel difference between adducin and other previously described capping proteins is that it is down-regulated by calmodulin in the presence of calcium. The association of stoichiometric amounts of adducin with the short erythrocyte actin filaments in the membrane skeleton indicates that adducin could be the functional barbed end capper in erythrocytes and play a role in restricting actin filament length. Our experiments also suggest novel possibilities for calcium regulation of actin filament assembly by adducin in erythrocytes and at cell-cell contact sites in nonerythroid cells.
Collapse
Affiliation(s)
- P A Kuhlman
- Department of Cell Biology, The Scripps Research Institute, La Jolla, California 92037, USA
| | | | | | | |
Collapse
|
35
|
Lebart MC, Casanova D, Benyamin Y. Actin interaction with purified dystrophin from electric organ of Torpedo marmorata: possible resemblance with filamin-actin interface. J Muscle Res Cell Motil 1995; 16:543-52. [PMID: 8567941 DOI: 10.1007/bf00126438] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Abstract
We have purified dystrophin from Torpedo marmorata electric tissue by means of alkaline extraction in conjunction with an affinity chromatography column using anti-peptide antibodies. Using solution (cosedimentation) and solid phase experiments (sedimentation with Sepharose filamentous actin and ELISA), we have demonstrated that purified dystrophin is able to bind filamentous and monomeric actin. Using ELISA coupled with biotin labelled peptides and taking advantage of strong affinity binding of streptavidin-biotin complex, we have identified two exposed sequences of the actin molecule implicated in dystrophin binding: fragment 40-113, further restricted to peptide 75-106 and peptide 360-372. In a previous study, we have shown that fragment 40-113 displays binding site(s) for filamin but probably not for alpha-actinin. Moreover, we have recently reported that alpha-actinin and filamin display divergent behaviours towards conformational changes of actin. In this study, we have demonstrated that, similarly to filamin, dystrophin binding is insensitive to the locking of actin in a monomeric conformation. Taken together, these results lead us to favour the idea that dystrophin could share properties in common with filamin in its binding of actin.
Collapse
Affiliation(s)
- M C Lebart
- Centre de Recherche de Biochimie Macromoléculaire, U. 249 Institut National de la Santé et de la Recherche Médicale, Laboratoire de Recherche sur la Motilité Cellulaire, Ecole Pratique des Hautes Etudes, Université de Montpellier I, BP 5051, France
| | | | | |
Collapse
|
36
|
Papa I, Méjean C, Lebart MC, Astier C, Roustan C, Benyamin Y, Alvarez C, Verrez-Bagnis V, Fleurence J. Isolation and properties of white skeletal muscle alpha-actinin from sea-trout (Salmo trutta) and bass (Dicentrarchus labrax). Comp Biochem Physiol B Biochem Mol Biol 1995; 112:271-82. [PMID: 7584856 DOI: 10.1016/0305-0491(95)00095-x] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
Fish alpha-actinin purified from sea-trout and bass white muscle by means of two different extraction procedures was used to investigate the eventual presence of different muscle isoforms in Z-disks. These fish alpha-actinins have the same apparent molecular weight (100 kDa) and the same isoelectric point (pI = 5.6), and also have a total antigenic identity towards anti-bass and anti-chicken alpha-actinin antibodies, suggesting a single molecular species. The role of fish alpha-actinin as an anchorage site for thin actin filaments and elastic titin filaments in Z-bands was studied. Despite conservation of the actin-binding site, fish alpha-actinin has a better actin-binding ability (kD = 0.3 microM) than chicken smooth muscle alpha-actinin (kD = 1.6 microM). Several other structural and functional characteristics of fish alpha-actinin were also studied: conservation of sequence and domain structure, the role of divalent ions (Ca2+, Mg2+) and the dielectric constant of the medium in alpha-actinin-actin interaction. Although the reason for fish white muscle alpha-actinin's close affinity to actin was not clearly established, our results suggested that the physicochemical environment of the Z-filaments in Z-disks might be crucial.
Collapse
Affiliation(s)
- I Papa
- UPR 9008 (CNRS), U. 249 (INSERM), Laboratoire de Recherche sur la Motilité Cellulaire, (EPHE), Université de Montpellier I, France
| | | | | | | | | | | | | | | | | |
Collapse
|
37
|
Bárány K, Bárány M, Giometti CS. Polyacrylamide gel electrophoretic methods in the separation of structural muscle proteins. J Chromatogr A 1995; 698:301-32. [PMID: 7773366 DOI: 10.1016/0021-9673(94)01189-l] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
Polyacrylamide gel electrophoresis plays a major role in analyzing the function of muscle structural proteins. This review describes one- and two-dimensional gel electrophoretic methods for qualitative and quantitative investigation of the muscle proteins, with special emphasis on determination of protein phosphorylation. The electrophoretic studies established the subunit structures of the muscle proteins, characterized their multiple forms, revealed changes in subunit composition or shifts in isoform distribution of specific proteins during development, upon stimulation or denervation of the muscle. Protein phosphorylation during muscle contraction is preferentially studied by two-dimensional gel electrophoresis. The same method demonstrated protein alterations in human neuromuscular diseases.
Collapse
Affiliation(s)
- K Bárány
- Department of Physiology and Biophysics, College of Medicine, University of Illinois at Chicago 60612-7342, USA
| | | | | |
Collapse
|
38
|
Xia D, Peng I. Deletion of amino acids from the carboxy-terminal end of actin. CELL MOTILITY AND THE CYTOSKELETON 1995; 32:163-72. [PMID: 8581973 DOI: 10.1002/cm.970320302] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Abstract
A series of deletions was made from the C-terminal end of actin by inserting termination codons into a full length cDNA of human alpha-skeletal muscle actin. These included deletions of 2, 3, 10, 20, 30, and 40 amino acids. The cDNA clones were transcribed and the resulting mRNAs were translated in vitro using 35S-labeled methionine. The 35S-labeled actin and actin mutants were then tested for the ability to coassemble with carrier actin, bind DNAse I, bind myosin S-1, bind a 27 kDa proteolytic fragment of alpha-actinin, and incorporate into myofibrils in vitro. Removal of the C-terminal two or three amino acids did not grossly alter the properties of actin tested. Deletion of an additional 7 amino acids (10 amino acids total) significantly decreased coassembly, binding to DNAse I, and incorporation into myofibrils, but did not dramatically reduce binding to myosin S-1 or the 27 kDa fragment of alpha-actinin. Deletion of 20 or more amino acids virtually abolished all normal actin function tested. By examining the structure of actin, we propose that the effect of removing residues 356-365 is due to the important role Trp356 plays in maintaining hydrophobic bonds between three non-contiguous segments of actin. We also suggest that removal of residues 366-372 adversely affected the structure or orientation of the DNAse I binding loop and that this change can account for defects in actin binding to DNAse I, coassembly with wild type actin, and incorporation into myofibrils.
Collapse
Affiliation(s)
- D Xia
- Department of Neuroscience and Cell Biology, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, Piscataway 08854, USA
| | | |
Collapse
|
39
|
Milzani A, DalleDonne I, Colombo R. N-ethylmaleimide-modified actin filaments do not bundle in the presence of alpha-actinin. Biochem Cell Biol 1995; 73:116-22. [PMID: 7662311 DOI: 10.1139/o95-014] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023] Open
Abstract
We show that the modification of actin subdomain 1 by N-ethylmaleimide (NEM), which binds Cys-374 close to the C-terminus of the molecule, inhibits the alpha-actinin-induced bundling of actin filaments. This effect is not merely related to the block of Cys-374, since N-(1-pyrenyl)iodoacetamide (pyrene-IA) is unable to prevent bundling. Considering that NEM (but not pyrene-IA) influences actin assembly, we suggest that the inhibition of the actin-alpha-actinin interaction is due to the chemical modification of actin Cys-374 which, by inducing a marked spatial reorganization of actin monomers, is able to modify both the intra- and inter-molecular interactions of this protein. Finally, NEM-modified actin filaments form bundles in the presence of polyethylene glycol 6000 since, in this case, the side by side association of actin filaments does not depend on the accessibility of binding sites nor on the formation of chemical bonds.
Collapse
Affiliation(s)
- A Milzani
- University of Milan, Dept. of Biology, Milan, Italy
| | | | | |
Collapse
|
40
|
Kuhlman PA, Ellis J, Critchley DR, Bagshaw CR. The kinetics of the interaction between the actin-binding domain of alpha-actinin and F-actin. FEBS Lett 1994; 339:297-301. [PMID: 8112470 DOI: 10.1016/0014-5793(94)80434-6] [Citation(s) in RCA: 30] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
Measurement of the binding equilibrium for the interaction of alpha-actinin with F-actin is complicated by secondary reactions involving cross-linking and/or bundling of the actin filaments. To quantitate the initial binding event, we studied the interaction of the bacterially expressed actin-binding domain (ABD) of chick smooth muscle alpha-actinin with F-actin. Stopped-flow measurements revealed a quench in protein fluorescence and an enhancement in light scattering when ABD binds to F-actin yielding second order rate constants for association of 2 x 10(5), 1.8 x 10(6) and 4 x 10(6) M-1.s-1 at 5 degrees C, 15 degrees C and 25 degrees C, respectively. At the latter two temperatures the dissociation rate constants were 1.5 and 9.6s-1, giving equilibrium constants of 0.83 and 2.4 microM, respectively. Optical changes on mixing intact alpha-actinin with F-actin were dominated by secondary bundling events.
Collapse
Affiliation(s)
- P A Kuhlman
- Department of Biochemistry, University of Leicester, UK
| | | | | | | |
Collapse
|
41
|
Lebart M, Méjean C, Casanova D, Audemard E, Derancourt J, Roustan C, Benyamin Y. Characterization of the actin binding site on smooth muscle filamin. J Biol Chem 1994. [DOI: 10.1016/s0021-9258(17)41775-3] [Citation(s) in RCA: 26] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
42
|
Abstract
Recent studies have greatly expanded our understanding of actin-bundling proteins. A new group of actin-bundling proteins, the fascins, has been recognized. An actin-bundling protein inhibits actin depolymerization even under conditions in which it cannot produce a gel, which suggests that bundling proteins may affect actin filament dynamics. A villin-like protein is present in Dictyostelium, shedding doubt on current ideas on the evolution of villin. Domain mapping continues to be a major thrust of research into most groups of bundling proteins.
Collapse
Affiliation(s)
- J J Otto
- Department of Biological Sciences, Purdue University, West Lafayette, IN 47907-1392
| |
Collapse
|